Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996).
about
Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsyIntravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy.High-performance liquid chromatographic analysis of lacosamide in canine serum using ultraviolet detection: application to pre-clinical pharmacokinetics in dogs.Treatment of epilepsy in China: Formal or informal.Canine status epilepticus: a translational platform for human therapeutic trials.Canine status epilepticus treated with fosphenytoin: A proof of principle study.International Veterinary Epilepsy Task Force's current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogsRetrospective epidemiological study of canine epilepsy in Japan using the International Veterinary Epilepsy Task Force classification 2015 (2003-2013): etiological distribution, risk factors, survival time, and lifespan.Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.Levetiracetam rectal administration in healthy dogs.Idiopathic epilepsy in the Italian Spinone in the United Kingdom: prevalence, clinical characteristics, and predictors of survival and seizure remissionRisk factors for survival in a university hospital population of dogs with epilepsy.The seizuring cat. Diagnostic work-up and therapy.Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs.Status epilepticus in dogs and cats, part 1: etiopathogenesis, epidemiology, and diagnosis.Status epilepticus in dogs and cats, part 2: treatment, monitoring, and prognosis.2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs.Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.Placement of deep brain electrodes in the dog using the Brainsight frameless stereotactic system: a pilot feasibility study.Pharmacokinetics of oral rufinamide in dogs.The pharmacokinetics of midazolam after intravenous, intramuscular, and rectal administration in healthy dogs.A Subset of Dogs with Presumptive Idiopathic Epilepsy Show Hippocampal Asymmetry: A Volumetric Comparison with Non-Epileptic Dogs Using MRI.Quality-of-life aspects in idiopathic epilepsy in dogs.Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus.
P2860
Q21558792-DD80155A-A714-487A-BB8B-F953DB73958FQ30830721-432D8CCD-C9B8-4F34-B1C9-F63BAC3AF8A4Q34013089-7B0B5E07-658F-4453-93D7-42B9B29F7BD1Q35245431-0ABC0FBC-E58D-44BC-949A-EDB9E0C2E771Q35446391-47353F7A-28A2-4953-A724-7C66BD01300BQ35688561-1DD7DD67-D467-4AA3-B343-A520F2F90D0DQ35758330-503D9B5F-3EF9-45D2-AED6-0ADCA25EEE9EQ36188009-4C408108-9BE5-4F36-94D2-81750AF9E526Q36259058-833F1BC2-1287-417D-8F85-C69B93B8987DQ36259210-4FD1195F-FBFF-49A6-8D7E-47909B71CE6FQ36873335-CB078011-1E25-4310-97F0-0D8D6F58F28AQ36974900-B235954A-AD47-42BB-93AD-31491EB10B4AQ36975502-F69A473D-1BC1-4A78-A5C7-AF2E9970A288Q37457534-7C2B0EFB-025D-4F4F-81DA-2278DC0CB949Q38592689-1EBB1F83-99FC-4D2B-8069-0C0746CFD0D3Q38818483-05866A04-309B-45B4-B8AE-CAE168B965FBQ38818494-19C98C3B-7F64-4E7B-B304-58EAB6A5FC5EQ38905308-6506F895-729B-4649-8002-5F05647AE876Q41001770-9AE27E21-4BCA-4A29-9465-9DD69CE586A5Q42133519-FE658097-AF77-4619-B9B2-F85224C7D15FQ43452297-566E89A8-93F0-4AAC-974B-03CE6692CB26Q44866918-4D5659C2-E160-4259-86FB-CA1941568AAFQ47109647-E1393666-F104-46AA-84ED-C6CD84A2FF16Q47718380-66A2987A-6CBC-4F10-ACC3-5EBEB1314E25Q48190757-74EF5965-516C-422D-B548-61251074079DQ55309579-ED7FBA05-2C40-438C-991D-AD458E7C2A10
P2860
Risk factors for development of status epilepticus in dogs with idiopathic epilepsy and effects of status epilepticus on outcome and survival time: 32 cases (1990-1996).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Risk factors for development o ...... al time: 32 cases (1990-1996).
@en
Risk factors for development o ...... me and survival time: 32 cases
@nl
type
label
Risk factors for development o ...... al time: 32 cases (1990-1996).
@en
Risk factors for development o ...... me and survival time: 32 cases
@nl
prefLabel
Risk factors for development o ...... al time: 32 cases (1990-1996).
@en
Risk factors for development o ...... me and survival time: 32 cases
@nl
P2093
P1476
Risk factors for development o ...... al time: 32 cases (1990-1996).
@en
P2093
P304
P356
10.2460/JAVMA.2001.219.618
P407
P577
2001-09-01T00:00:00Z